BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Engineering Safety and Developability for Complex Antibody-Bas
 ed Therapeutics.\n\nThe Antibody and Fusion Protein Engineering and Devel
 opability Summit returns as the protein developers' playbook on selecting
  and engineering the billion-dollar candidate\, that can pair the right b
 iology with a smooth progression through development.\n\nUniting 80+ prot
 ein and antibody discovery leads\, development scientists and antibody en
 gineers\, the Summit will equip you to take the guess work out of fusion 
 and antibody-derived protein drug development\, reducing drug development
  cost and time which has never been so important than in today's funding 
 environment.\n\nURLs:Tickets: https://go.evvnt.com/2291577-2?pid=185Broch
 ure: https://go.evvnt.com/2291577-3?pid=185\n\nTime: 8:00 AM - 6:00 PM\n\
 nSpeakers: Abhinav Gupta\, Senior Scientist I\, AI Innovation-Antibody\, 
 Sanofi\, Brian Hall\, Head of Biologics Characterization\, Expression and
  Purification Distinguished Scientist\, Sanofi\, Christopher Wassif\, Dir
 ector - Molecular Engineering and Antibody Technologies\, AstraZeneca\, H
 oracio Nastri\, Vice President - Protein Science and Technology\, Incyte\
 , Jane Guo\, Principal Scientist/Lab Head\, Sanofi\, Jeffrey Way\, Presid
 ent\, Wyss Institute at Harvard University\, Jessica Wiwczar\, Senior Sci
 entist II Bioprocess And Early Development Protein Sciences\, Invenra Inc
 .\, Jijun Dong\, Chief Scientific Officer\, Salubris Biotherapeutics\, Ji
 nsam You\, Vice President Of Development\, INGENIA Therapeutics\, Joel Co
 hen-Solal\, Principal Scientist\, Fc Biology\, Abbvie\, Julien Lafrance-V
 anasse\, Senior Principal Scientific Researcher in Antibody Engineering\,
  Genentech\, Kevin Dagbay\, Principal Scientist\, Keros Therapeutics\, Mi
 chael Dyson\, Vice President - Antibody Discovery and Engineering\, Ichno
 s Science\, Nina Weisser\, Director - Multispecific Antibody Therapeutics
 \, Zymeworks\, Paula Fraenkel\, Executive Director - Global Project and O
 ncology Lead\, AstraZeneca\, Rajika Perera\, Co-Founder and Chief Executi
 ve Officer\, Poseidon LLC\, Roee Ramot\, Senior Scientist II\, Antibody D
 iscovery Scientist and Automation\, Novartis\, Rosa Grenha\, Director of 
 Protein Biochemistry\, Keros Therapeutics\, Sagar Kathuria\, Senior Princ
 ipal Scientist\, Sanofi\, Sasha Ebrahimi\, Principal Investigator\, Glaxo
 SmithKline Plc\, Thach Mai\, Director of Discovery and Platform\, Juvena 
 Therapeutics\, Wenhua Wang\, Senior Staff Scientist\, Regeneron\n
DTEND:20240620T180000
DTSTAMP:20260512T220333Z
DTSTART:20240618T080000
LOCATION:Hilton Boston Logan Airport\, One\, Hotel Drive\, Boston\, Massac
 husetts\, 02128\,
SEQUENCE:0
SUMMARY:Engineering Safety and Developability for Complex Antibody-Based T
 herapeutics.\nThe Antibody and Fusion Protein Engineering and Developabil
 ity Summ...
UID:efc720e1-c9e6-4b12-ba80-d97efb622e6c
END:VEVENT
END:VCALENDAR